Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
PUT
KraneShares CSI China Internet ETF
KWEB
$5.2B
| $2.64M | ﹤0.01% |
80,500
| – | – |
|
|
JBGS
3377
JBG SMITH
JBGS
$708M
| $2.63M | ﹤0.01% |
111,374
+68,580
| +160% | +$1.77M |
|
3378
JPMorgan Equity Premium Income ETF
JEPI
$46.2B
| $2.63M | ﹤0.01% |
+47,381
| New | +$2.74M |
|
3379
Olema Pharmaceuticals
OLMA
$899M
| $2.62M | ﹤0.01% |
643,344
+557,927
| +653% | +$1.77M |
|
3380
Anavex Life Sciences
AVXL
$277M
| $2.62M | ﹤0.01% |
+261,292
| New | +$2.47M |
|
3381
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$299M
| $2.62M | ﹤0.01% |
100,000
-100,000
| -50% | -$2.54M |
|
|
PSTX
3382
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.61M | ﹤0.01% |
1,012,515
+177,929
| +21% | +$495K |
|
|
FVAM
3383
DELISTED
5:01 Acquisition Corp
FVAM
| $2.61M | ﹤0.01% |
263,504
-13,504
| -5% | -$133K |
|
|
DVAX
3384
DELISTED
Dynavax Technologies
DVAX
| $2.61M | ﹤0.01% |
207,078
-1,494,031
| -88% | -$15.9M |
|
3385
Root
ROOT
$874M
| $2.61M | ﹤0.01% |
121,675
-164,175
| -57% | -$4.45M |
|
3386
NetEase
NTES
$78.6B
| $2.6M | ﹤0.01% |
27,809
-516,901
| -95% | -$49.2M |
|
3387
Carlyle Secured Lending
CGBD
$811M
| $2.6M | ﹤0.01% |
204,366
+103,933
| +103% | +$1.46M |
|
|
PRLHU
3388
DELISTED
Pearl Holdings Acquisition Corp Unit
PRLHU
| $2.59M | ﹤0.01% |
260,702
| – | – |
|
|
PMGM
3389
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
| $2.59M | ﹤0.01% |
261,419
-1,119
| -0.4% | -$11.1K |
|
3390
PUT
Arcus Biosciences
RCUS
$3.72B
| $2.59M | ﹤0.01% |
102,300
-39,600
| -28% | -$970K |
|
|
LJAQ
3391
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
| $2.59M | ﹤0.01% |
259,184
+210,119
| +428% | +$2.09M |
|
3392
CALL
Philips
PHG
$26.1B
| $2.58M | ﹤0.01% |
140,145
-465,166
| -77% | -$10M |
|
3393
CALL
AutoZone
AZO
$48.4B
| $2.58M | ﹤0.01% |
1,200
+1,000
| +500% | +$2.06M |
|
3394
CEL-SCI Corp
CVM
$27.4M
| $2.58M | ﹤0.01% |
19,090
+12,984
| +213% | +$1.35M |
|
3395
CALL
Myriad Genetics
MYGN
$302M
| $2.58M | ﹤0.01% |
141,800
-8,200
| -5% | -$170K |
|
3396
PUT
Lucid Motors
LCID
$1.97B
| $2.57M | ﹤0.01% |
+15,000
| New | +$2.85M |
|
|
CCTS
3397
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
| $2.57M | ﹤0.01% |
258,351
+215,500
| +503% | +$2.14M |
|
3398
BOK Financial
BOKF
$8.35B
| $2.57M | ﹤0.01% |
+33,986
| New | +$2.87M |
|
|
WRAC
3399
DELISTED
Williams Rowland Acquisition Corp.
WRAC
| $2.57M | ﹤0.01% |
256,605
+40,010
| +18% | +$400K |
|
|
ATCO
3400
DELISTED
Atlas Corp.
ATCO
| $2.56M | ﹤0.01% |
239,287
-472,215
| -66% | -$5.93M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.